Aug 10, 2026
UK becomes first European country to approve Eli Lilly's once-daily weight loss pill Foundayo
The UK's Medicines and Healthcare products Regulatory Agency has authorized orforglipron (brand name Foundayo), a once-daily oral medication from Eli Lilly for treating obesity and type 2 diabetes, making the UK the first country in Europe to approve the drug.
6 sources
00